Taro Inks $36M Investor Deal Over Generics Price-Fixing

[Gunnar Larson]

Taro Inks $36M Investor Deal Over Generics Price-Fixing
<https://www.law360.com/competition/articles/1825670?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-04-16&read_main=1&nlsidx=0&nlaidx=1>

By Lauren Berg

Taro Pharmaceutical Industries shareholders asked a New York federal judge
Monday to greenlight a $36 million settlement resolving proposed class
claims that the company misled investors about alleged generic drug
price-fixing that led to a drop in stock price upon news of a U.S.
Department of Justice antitrust investigation.

 Motion attached | Read full article »
<https://www.law360.com/competition/articles/1825670?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-04-16&read_more=1&nlsidx=0&nlaidx=1>
 | Save to favorites »
<https://www.law360.com/competition/articles/1825670?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-04-16&read_later=1&nlsidx=0&nlaidx=1>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: text/html
Size: 2514 bytes
Desc: not available
URL: <https://lists.cpunks.org/pipermail/cypherpunks/attachments/20240416/ce6a9d44/attachment.txt>